Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

PET imaging uncovers a surprising new way COVID-19 affects the heart

A new study in JACC: Cardiovascular Imaging focuses on a potential new side effect of COVID-19, highlighting the continued importance of monitoring these patients going forward. 

Thumbnail

TAVR programs follow inconsistent DNR policies, potentially skewing data

Not all hospitals respect the written preferences of patients, possibly motivated by a desire to report better TAVR outcomes.

Thumbnail

Moderate aortic stenosis linked to a significant risk of death—should earlier interventions be considered?

Researchers tracked data from more than 12,000 moderate AS patients who originally participated in one of 25 different studies. While the findings seem to suggest earlier treatment could be beneficial for certain high-risk patients, additional research is still required.

Thumbnail

Cardiac MRI reveals that even competitive athletes are subject to reduced cardiac function after COVID

Compared to healthy controls, the COVID group displayed significantly worse global and segmental circumferential systolic strain.

Vascular CT beyond the coronaries includes imaging for aortic aneurism, aortic dissection, SCAD and fibromuscular dysplasia. #SCCT #SCCT2022 #SCAD #yescct

VIDEO: Vascular imaging applications for CT beyond the heart

Society of Cardiovascular Computed Tomography (SCCT) President Brian Ghoshhajra, MD, explains the vascular imaging sessions at SCCT 2022 that went beyond the usual coronaries and structural heart evaluations.

cardiologist patient heart compensation starting salary 2022 interventional cardiologist

Atrial cardiomyopathy tied to a higher risk of dementia, even when patients show no signs of AFib or stroke

Researchers examined decades of data from more than 5,000 patients, sharing their findings in the Journal of the American Heart Association.

Thumbnail

AFib screening using wearable devices found to be cost-effective for patients as young as 50

While current guidelines endorse screening for people aged 65 and above, a massive simulation published in JAMA Health Forum suggests that cost-effectiveness may extend to even younger age groups.

coronary CTA

Deep learning, subtraction technique ideal for evaluating stent re-stenosis on coronary CTA

Detecting in-stent restenosis via coronary CTA with hybrid iterative reconstruction has historically been an exercise in avoiding false positives.